Follow
Caitlin MacCarthy
Caitlin MacCarthy
Max Planck Institute for Molecular Medicine
Verified email at mpi-muenster.mpg.de
Title
Cited by
Cited by
Year
Excluding Oct4 from Yamanaka cocktail unleashes the developmental potential of iPSCs
S Velychko, K Adachi, KP Kim, Y Hou, CM MacCarthy, G Wu, HR Schöler
Cell Stem Cell 25 (6), 737-753. e4, 2019
1112019
Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency
N Tapia, C MacCarthy, D Esch, A Gabriele Marthaler, U Tiemann, ...
Scientific reports 5 (1), 13533, 2015
802015
Caveolin‐1 promotes resistance to chemotherapy‐induced apoptosis in Ewing's sarcoma cells by modulating PKCα phosphorylation
OM Tirado, CM MacCarthy, N Fatima, J Villar, S Mateo‐Lozano, V Notario
International journal of cancer 126 (2), 426-436, 2010
632010
PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase Cδ–dependent mechanism
J Villar, MI Arenas, CM MacCarthy, MJ Blanquez, OM Tirado, V Notario
Cancer research 67 (22), 10859-10868, 2007
572007
Local flexibility in molecular function paradigm
J Bhalla, GB Storchan, CM MacCarthy, VN Uversky, O Tcherkasskaya
Molecular & Cellular Proteomics 5 (7), 1212-1223, 2006
572006
Nucleosomal DNA dynamics mediate Oct4 pioneer factor binding
J Huertas, CM MacCarthy, HR Schöler, V Cojocaru
Biophysical Journal 118 (9), 2280-2296, 2020
462020
Changing POU dimerization preferences converts Oct6 into a pluripotency inducer
S Jerabek, CKL Ng, G Wu, MJ Arauzo‐Bravo, KP Kim, D Esch, V Malik, ...
EMBO reports 18 (2), 319-333, 2017
452017
Reprogramming competence of OCT factors is determined by transactivation domains
KP Kim, Y Wu, J Yoon, K Adachi, G Wu, S Velychko, CM MacCarthy, ...
Science advances 6 (36), eaaz7364, 2020
342020
Fusion of reprogramming factors alters the trajectory of somatic lineage conversion
S Velychko, K Kang, SM Kim, TH Kwak, KP Kim, C Park, K Hong, ...
Cell Reports 27 (1), 30-39. e4, 2019
232019
Oct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells
L Xiong, EA Tolen, J Choi, S Velychko, L Caizzi, T Velychko, K Adachi, ...
Elife 11, e71533, 2022
182022
A balanced Oct4 interactome is crucial for maintaining pluripotency
D Han, G Wu, R Chen, HCA Drexler, CM MacCarthy, KP Kim, K Adachi, ...
Science advances 8 (7), eabe4375, 2022
172022
The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family
CM MacCARTHY, V Notario
International journal of oncology 43 (4), 1244-1252, 2013
152013
OCT4 interprets and enhances nucleosome flexibility
CM MacCarthy, J Huertas, C Ortmeier, H Vom Bruch, DS Tan, D Reinke, ...
Nucleic acids research 50 (18), 10311-10327, 2022
142022
Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17
H Hu, DHH Ho, DS Tan, CM MacCarthy, C Yu, M Weng, HR Schöler, ...
Nucleic Acids Research 51 (17), 8934-8956, 2023
42023
Highly cooperative chimeric super-SOX induces naive pluripotency across species
CM MacCarthy, G Wu, V Malik, Y Menuchin-Lasowski, T Velychko, ...
Cell Stem Cell 31 (1), 127-147. e9, 2024
32024
Enhancing Sox/Oct cooperativity induces higher-grade developmental reset
CM MacCarthy, V Malik, G Wu, T Velychko, G Keshet, R Jauch, ...
bioRxiv, 2022.09. 23.509242, 2022
22022
Oct4 interprets and enhances nucleosome dynamics
JH Martin, CM MacCarthy, V Cojocaru, H Schöler
Biophysical Journal 122 (3), 170a, 2023
2023
Breaths, twists, and turns of free and interacting atomistic nucleosomes
J Huertas, C MacCarthy, HR Schöler, V Cojocaru
Biophysical Journal 121 (3), 5a, 2022
2022
Oct4 Pioneers Genomic Nucleosomes in Motion
J Huertas, C MacCarthy, HR Schoeler, V Cojocaru
Biophysical Journal 120 (3), 139a, 2021
2021
Simulating the binding of Pioneer Transcription Factors to the nucleosome
J Huertas, CM Maccarthy, HR Schoeler, V Cojocane
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48, S88-S88, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20